Cargando…

Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report

RATIONALE: C3 glomerulonephritis (C3GN) and complement-mediated hemolytic uremic syndrome (HUS) both result from the abnormal regulation of the complement system. A significant number of patients with C3GN or complement-mediated HUS have mutations of more than 1 complement protein. This discovery ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Pei, Zhu, Li, Yu, Feng, Han, Sha-Sha, Meng, Si-Jun, Guo, Wei-yi, Zhang, Hong, Song, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478328/
https://www.ncbi.nlm.nih.gov/pubmed/28614243
http://dx.doi.org/10.1097/MD.0000000000007144
Descripción
Sumario:RATIONALE: C3 glomerulonephritis (C3GN) and complement-mediated hemolytic uremic syndrome (HUS) both result from the abnormal regulation of the complement system. A significant number of patients with C3GN or complement-mediated HUS have mutations of more than 1 complement protein. This discovery has had a major impact on identifying the underlying cause of familial C3GN or complement-mediated HUS. PATIENT CONCERNS: We report the cases of 2 brothers (herein referred to as patient II-1 and patient II-9), both with complement disorders that differed in their clinical and genetic features. DIAGNOSES: Patient II-1 clinically presented with nephrotic syndrome and acute kidney injury and pathologically presented with C3GN combined with thrombotic microangiopathy (TMA) and subacute tubulointerstitial nephritis. Meanwhile, patient II-9 clinically presented with HUS and pathologically presented with TMA combined with acute severe tubular injury. INTERVENTIONS: Screenings for genetic mutations contributed to complement system dysregulation were performed on patient II-1. OUTCOMES: The genome sequencing identified that patient II-1 had a heterozygous mutation in the C3 gene (c.C1774T/p.R592W). Nine other relatives of the brothers were checked for this C3 mutation and only the daughter of patient II-1 (herein referred to as patient III-2) carried it, but so far, she does not have any clinical manifestations of kidney disease. LESSIONS: Family members with a dysregulation of the complement alternative pathway may differ in its clinical and genetic features.